Answer to your remark:
"You know that stuff is over my head". I beg to differ, it is not. Staying with Galera for a while. I did some experimenting with those swim-lane values. It seems that even that difference between treatment and placebo should be enough for success in phase 3. My biggest worry is this: what ever I try, I am unable to reconcile placebo swim-lanes with other Galera data for placebo. Maybe they censored some subjects - I don't like that. Well, we should see in October-November time frame.
As to any future IPIX P3 trial. Nobody knows. I am afraid when one possibly comes along, Leo The Clinical Skin-Flint somehow manages to run too small trial, again. I am fairly certain that if either SOM or UPS trial had been done with properly sized population, not with moonshot population, we would now be discussing when we think IPIX P3 results are coming out.
Of course, some will point to thin funds when those trials were done.
News 
Market Data 
Discover 
